How Much of a Cancer Drug Is Too Much? Patients, Researchers Challenge FDA-Approved Dosages

Billions in savings sitting in the gap between the approved dose and the effective one.

Patients and researchers point to evidence that many cancer drug dosages are excessive, and that reducing the amount and frequency could save billions of dollars and prevent some of the worst side effects.

Read it at KFF Health News ↗

← Front page